Decreased Serum Antioxidant Marker is Predictive of Early Recurrence in the Same Segment after Radical Ablation for Hepatocellular Carcinoma

被引:0
作者
Muro, Taiko [1 ]
Nakamura, Shinichiro [1 ]
Takaki, Akinobu [1 ]
Onishi, Hideki [1 ]
Wada, Nozomu [1 ]
Yasunaka, Tetsuya [1 ]
Uchida, Daisuke [1 ]
Oyama, Atsushi [1 ]
Adachi, Takuya [1 ]
Shiraha, Hidenori [1 ]
Okada, Hiroyuki [1 ]
机构
[1] Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan
关键词
oxidative stress; hepatocellular carcinoma; recurrence; radiofrequency ablation; RADIOFREQUENCY ABLATION; OXIDATIVE STRESS; RISK-FACTORS; RESECTION; LIVER; TRIAL;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) is a promising method for controlling tumors, although it does not entirely eliminate recurrence. Oxidative stress is associated with the progression of hepatocarcinogenesis, while also acting as an anticancer response. The objective of the present study was to investigate the factors influencing post- RFA outcomes. We recruited 235 newly diagnosed HCC patients who received RFA for single tumors. The patients with recurrence were sub-grouped into early and segmental recurrence groups. The characteristics of the sub-grouped patients were evaluated, including by measuring oxidative stress marker reactive oxygen metabolites and antioxidant marker OXY-adsorbent tests. The factors associated with poor survival were a high Child-Pugh score and early recurrence within 2 years in the same segment. The patients who experienced recurrence within 2 years in the same segment showed a larger tumor diameter than did others. According to a multivariate analysis, the OXY values were also significantly low in these patients. In conclusion, maintaining the antioxidant reservoir function with a high OXY value might be necessary to prevent early recurrence within the RFA-treated segment.
引用
收藏
页码:275 / 283
页数:9
相关论文
共 33 条
[1]   A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma [J].
Chen, MS ;
Li, JQ ;
Zheng, Y ;
Guo, RP ;
Liang, HH ;
Zhang, YQ ;
Lin, XJ ;
Lau, WY .
ANNALS OF SURGERY, 2006, 243 (03) :321-328
[2]   Oxidative Stress, Systemic Inflammation, and Severe Periodontitis [J].
D'Aiuto, F. ;
Nibali, L. ;
Parkar, M. ;
Patel, K. ;
Suvan, J. ;
Donos, N. .
JOURNAL OF DENTAL RESEARCH, 2010, 89 (11) :1241-1246
[3]   Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer [J].
Espey, Michael Graham ;
Chen, Ping ;
Chalmers, Brian ;
Drisko, Jeanne ;
Sun, Andrew Y. ;
Levine, Mark ;
Chen, Qi .
FREE RADICAL BIOLOGY AND MEDICINE, 2011, 50 (11) :1610-1619
[4]   High concentrations of ascorbic acid induces apoptosis of human gastric cancer cell by p38-MAP kinase-dependent up-regulation of transferrin receptor [J].
Ha, Yu Mi ;
Park, Min Kyu ;
Kim, Hye Jung ;
Seo, Han Geuk ;
Lee, Jae Heun ;
Chang, Ki Churl .
CANCER LETTERS, 2009, 277 (01) :48-54
[5]   Prognostic impact of anatomic resection for hepatocellular carcinoma [J].
Hasegawa, K ;
Kokudo, N ;
Imamura, H ;
Matsuyama, Y ;
Aoki, T ;
Minagawa, M ;
Sano, K ;
Sugawara, Y ;
Takayama, T ;
Makuuchi, M .
ANNALS OF SURGERY, 2005, 242 (02) :252-259
[6]   Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide survey [J].
Hasegawa, Kiyoshi ;
Kokudo, Norihiro ;
Makuuchi, Masatoshi ;
Izumi, Namiki ;
Ichida, Takafumi ;
Kudo, Masatoshi ;
Ku, Yonson ;
Sakamoto, Michiie ;
Nakashima, Osamu ;
Matsui, Osamu ;
Matsuyama, Yutaka .
JOURNAL OF HEPATOLOGY, 2013, 58 (04) :724-729
[7]   AASLD guidelines for the treatment of hepatocellular carcinoma [J].
Heimbach, Julie K. ;
Kulik, Laura M. ;
Finn, Richard S. ;
Sirlin, Claude B. ;
Abecassis, Michael M. ;
Roberts, Lewis R. ;
Zhu, Andrew X. ;
Murad, M. Hassan ;
Marrero, Jorge A. .
HEPATOLOGY, 2018, 67 (01) :358-380
[8]   Non-tumor adjacent tissue of advanced stage from CRC shows activated antioxidant response [J].
Hernandez-Lopez, Reyniel ;
Torrens-Mas, Margalida ;
Pons, Daniel G. ;
Company, Maria M. ;
Falco, Esther ;
Fernandez, Teresa ;
Ibarra de la Rosa, Javier M. ;
Sastre-Serra, Jorge ;
Oliver, Jordi ;
Roca, Pilar .
FREE RADICAL BIOLOGY AND MEDICINE, 2018, 126 :249-258
[9]   Increased p53 mutation load in nontumorous human liver of Wilson disease and hemochromatosis:: Oxyradical overload diseases [J].
Hussain, SP ;
Raja, K ;
Amstad, PA ;
Sawyer, M ;
Trudel, LJ ;
Wogan, GN ;
Hofseth, LJ ;
Shields, PG ;
Billiar, TR ;
Trautwein, C ;
Höhler, T ;
Galle, PR ;
Phillips, DH ;
Markin, R ;
Marrogi, AJ ;
Harris, CC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (23) :12770-12775
[10]   Comparison of Outcomes of Hepatic Resection and Radiofrequency Ablation for Hepatocellular Carcinoma Patients with Multifocal Tumors Meeting the Barcelona-Clinic Liver Cancer Stage A Classification [J].
Jiang, Li ;
Yan, Lunan ;
Wen, Tianfu ;
Li, Bo ;
Zeng, Yong ;
Yang, Jiayin ;
Wang, Wentao ;
Xu, Mingqing ;
Wu, Hong .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2015, 221 (05) :951-961